Immunofluorescence Technique Using HeLa Cells Expressing Recombinant Nucleoprotein for Detection of Immunoglobulin G Antibodies to Crimean-Congo Hemorrhagic Fever Virus
Open Access
- 1 February 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 40 (2) , 372-375
- https://doi.org/10.1128/jcm.40.2.372-375.2002
Abstract
A HeLa cell line continuously expressing recombinant nucleoprotein (rNP) of the Crimean-Congo hemorrhagic fever virus (CCHFV) was established by transfection with an expression vector containing the cDNA of CCHFV NP (pKS336-CCHFV-NP). These cells were used as antigens for indirect immunofluorescence (IF) to detect immunoglobulin G antibodies to CCHFV. The sensitivity and specificity of this IF technique were examined by using serum samples and were compared to those of the IF technique using CCHFV-infected Vero E6 cells (authentic antigen). Staining of the CCHFV rNP expressed in HeLa cells showed a unique granular pattern similar to that of CCHFV-infected Vero E6 cells. Positive staining could easily be distinguished from a negative result. All 13 serum samples determined to be positive by using the authentic antigen were also determined to be positive by using CCHFV rNP-expressing HeLa cells (recombinant antigen). The 108 serum samples determined to be negative by using the authentic antigen were also determined to be negative by using the recombinant antigen. Thus, both the sensitivity and the specificity of this IF technique were 100% compared to the IF with authentic antigen. The novel IF technique using CCHFV rNP-expressing HeLa cells can be used not only for diagnosis of CCHF but also for epidemiological studies on CCHFV infections.Keywords
This publication has 27 references indexed in Scilit:
- The use of a reverse transcription–polymerase chain reaction for the detection of viral nucleic acid in the diagnosis of Crimean–Congo haemorrhagic feverJournal of Virological Methods, 1998
- Crimean Congo-Haemorrhagic Fever treated with oral ribavirinThe Lancet, 1995
- Serodiagnosis of Crimean-Congo haemorrhagic feverEpidemiology and Infection, 1994
- Blasticidin S deaminase gene from Aspergillus terreus (BSD): a new drug resistance gene for transfection of mammalian cellsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1994
- Detection of human antibodies to Crimean-Congo haemorrhagic fever virus using expressed viral nucleocapsid proteinJournal of General Virology, 1994
- Enzyme-linked immunosorbent assays for the detection of antibody to Crimean-Congo haemorrhagic fever virus in the sera of livestock and wild vertebratesEpidemiology and Infection, 1993
- Antigen-capture enzyme-linked immunosorbent assay for detection and quantification of Crimean-Congo hemorrhagic fever virus in the tick, Hyalomma truncatumJournal of Virological Methods, 1993
- Use of the human elongation factor 1α promoter as a versatile and efficient expression systemGene, 1990
- Antibodies against haemorrhagic fever viruses in Kenya populationsTransactions of the Royal Society of Tropical Medicine and Hygiene, 1983
- Review Article 1: The Epidemiology of Tick-Borne Crimean-Congo Hemorrhagic Fever in Asia, Europe, and Africa23Journal of Medical Entomology, 1979